ATORVASTATIN TREATMENT IMPROVES THE EFFECTS OF MESENCHYMAL STEM CELLS TRANSPLANTATION ON ACUTE MYOCARDIAL INFARCTION: THE ROLE OF RHOA/ROCK/ERK PATHWAY

Statins protects mesenchymal stem cells (MSCs) against the harsh micro-environment and improve the efficacy of MSCs transplantation after acute myocardial infarction (AMI). However, the mechanism underlying this protective role of statins remains uncertain. Also, the transdifferentiation potential